Attana and partners to develop biosensors using peptide matrices

Stockholm, April 18 th, 2017. Attana AB, Biogelx Ltd and University of Stuttgart, Institute of Cell Biology and Immunology, Prof. Kontermann’s group has been granted €500.000 from the Eurostars program supporting R&D performing SMEs. The grant is for development of sensitive cell-based biosensors using peptide matrices.

The project aims at developing biologically relevant tools for pre-clinical studies based on Attana´s cell-based 3rdgeneration biosensors, Biogelex´s 3D hydrogel matrix for cell growth and Prof. Kontermann’s leading knowledge in biotherapeutics. The tool will increase the success rate and cut the costs for pharmaceutical companies developing new drugs.

The project will adapt Biogelx peptide based 3D hydrogel technology to Attana´s sensor chips. The 3D gel-chips will offer a tissue-mimicking environment, ensuring increased biological relevance and high data quality. The new assays will be developed and validated according to the R&D processes used by Prof Kontermann´s group.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
tel: + 46 70 15676765

Our team provide customers with biologically relevant information to enhance their success rate and efficiency of research and development process. Our world leading cell interaction technology have been validated by academic institutions, biotech companies and big-pharma across the world. With a strong focus on characterizing molecular interactions exactly as they occur in the human body, Attana is committed to offer tools and services with the goal of enhancing success rates and efficiencies in the complex process of developing pharmaceuticals. Attana’s 3 rd generations biosensors are today used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.

We are located in Stockholm and have a strong footprint in Europe and Asia.

About Us

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit or contact


Documents & Links